Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Short-Term Debt issuances (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Short-Term Debt issuances for 7 consecutive years, with -$645.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-Term Debt issuances fell 778.95% to -$645.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $115.0 million, a 62.3% decrease, with the full-year FY2025 number at $115.0 million, down 62.3% from a year prior.
  • Short-Term Debt issuances was -$645.0 million for Q4 2025 at Acadia Healthcare Company, down from $645.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $760.0 million in Q1 2025 to a low of -$645.0 million in Q2 2025.
  • A 4-year average of $96.0 million and a median of $82.5 million in 2021 define the central range for Short-Term Debt issuances.
  • Biggest YoY gain for Short-Term Debt issuances was 1190.0% in 2025; the steepest drop was 778.95% in 2025.
  • Acadia Healthcare Company's Short-Term Debt issuances stood at $70.0 million in 2021, then plummeted by 42.86% to $40.0 million in 2023, then skyrocketed by 137.5% to $95.0 million in 2024, then tumbled by 778.95% to -$645.0 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Short-Term Debt issuances are -$645.0 million (Q4 2025), $645.0 million (Q3 2025), and -$645.0 million (Q2 2025).